In particular, to recapitulate the proliferative phase, organoids are exposed to an estrogen receptor (ER) agonist (typically E2), while a combination of E2 with a progesterone receptor (PGR) agonist (typically P4 or medroxyprogesterone acetate (MPA)) and decidualization-promoting cyclic adenosine monophosphate (cAMP) is employed to replicate the transition to the secretory phase [53, 54, 63]
Wang C, Su B, Lu S, Han S, Jiang H, Li Z, et al
Researchers in life sciences must follow protocols consistent with lab research standards
Pre-injection fasting window: Inject at least 2 to 3 hours after the last meal and avoid alcohol in the evening before injection
The good news is, these issues can be countered through an increase in muscle mass via resistance training, which is known to reduce the risk of metabolic health conditions